# Scribe Therapeutics (SCTX) — Overview

SCTX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/sctx

## Price

Last close $20.72 on Oct 15, 2026. 52-week range $16.21 – $37.25.

## Company profile

Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $33.3M |
| Revenue (quarter) | $1.9M |
| Revenue growth (year over year) | -60.84% |
| Gross profit (trailing twelve months) | $33.3M |
| Gross margin | 100.00% |
| Net income (trailing twelve months) | −$32.3M |
| Net income (quarter) | −$6.5M |
| Net income growth (year over year) | 34.60% |
| Net margin | -97.00% |
| Return on equity | 0.00% |
| EPS (trailing twelve months) | −$13.13 |
| Book value per share | $0.00 |
| P/E (trailing twelve months) | — |
| Price to book | — |
| Debt to assets | 176.80% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Scribe Therapeutics (SCTX) profitable?

No. Scribe Therapeutics reported a net loss of $32.3M over the trailing twelve months.

### How much revenue does Scribe Therapeutics (SCTX) make?

Scribe Therapeutics generated $33.3M in revenue over the trailing twelve months, down 60.84% year over year.

### How do I buy stock in Scribe Therapeutics (SCTX)?

SCTX trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).